Key result
Intraspinal narcotic analgesia carries associated clinical risks and costs that must be carefully evaluated.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Clinicians should weigh risks and costs before intraspinal narcotic use; Level 5 evidence leaves open need for confirmatory trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Philip R. Bromage (1981) studied this question. Intraspinal narcotic analgesia carries associated clinical risks and costs that must be carefully evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: